Scientist, preclinical biology

Spago Nanomedical AB (Publ) / Kemiingenjörsjobb / Lund
Observera att sista ansökningsdag har passerat.


Visa alla kemiingenjörsjobb i Lund, Lomma, Staffanstorp, Burlöv, Kävlinge eller i hela Sverige
Visa alla jobb hos Spago Nanomedical AB (Publ) i Lund

Position Description:
Spago Nanomedical is looking for a driven and talented scientist to join our Discovery team to help advance our pipeline of projects. This position offers an opportunity to participate in, and support our projects at different stages of preclinical development. You will work with other scientists with a passion for developing new nanomedical approaches toward the treatment and diagnosis of disease.

Responsibilities:
Design of in vivo studies in collaboration with a team of experienced co-workers
Managing out-sourcing and conduct of exploratory and regulatory preclinical studies
Communication, internal and external
Scientific reporting and publication
Participation in design of bioanalytical methods
Pharmacokinetics modeling at a high level, training will be offered according to needs

Requirements:
PhD in a relevant field
Permit to work in Sweden

We offer a stimulating work environment with a team of fun and talented colleagues, good facilities and resources.
Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment.
Submit your application at https://spagonanomedical.se/en/about-us/career/

Publiceringsdatum
2021-03-17

Så ansöker du
Sista dag att ansöka är 2021-04-16
Klicka på denna länk för att göra din ansökan

Adress
Spago Nanomedical AB (Publ)
Scheelevägen 22
22363 Lund

Omfattning
Detta är ett heltidsjobb.

Arbetsgivare
Spago Nanomedical AB (Publ) (org.nr 556574-5048)
Scheelevägen 22 (visa karta)
223 63  LUND

Arbetsplats
Spago Nanomedical AB Publ

Jobbnummer
5634636

Observera att sista ansökningsdag har passerat.

Prenumerera på jobb från Spago Nanomedical AB (Publ)

Fyll i din e-postadress för att få e-postnotifiering när det dyker upp fler lediga jobb hos Spago Nanomedical AB (Publ):